期刊文献+

小鼠FasL基因的克隆和在软骨细胞中表达 被引量:2

The cloning of mouse FasL gene and expression in chondrocytes
下载PDF
导出
摘要 目的 :获得小鼠FasL(mFasL)的cDNA克隆 ,通过逆转录病毒表达系统 pLNCX2 在软骨细胞中进行表达 ,并分析其功能。方法 :应用RT PCR和T A克隆技术 ,从激活的小鼠脾脏淋巴细胞总RNA中 ,扩增mFasLcDNA并克隆到T载体中 ,再亚克隆到 pLNCX2 中。转染软骨细胞后 ,以流式细胞仪检测mFasL蛋白的表达 ,以单向混合淋巴细胞反应鉴定其活性。结果 :成功地克隆了 0 .85 5kb的mFasLcDNA ,并经测序确证。通过 pLNCX2 转染软骨细胞 ,转染率为 6 0 .6 4 %。流式细胞仪检测到FasL蛋白的表达 ,并能显著抑制同种异体的单向混合淋巴细胞反应 ,刺激指数下调到未转染软骨细胞的11.71%。结论 :克隆到的mFasL基因 ,并能通过 pLNCX2 有效表达。 AIM: To clone mFasL cDNA, then insert it into retrovirus expression system pLNCX 2, and express mFasL cDNA in chondrocytes to study its function. METHODS: RT PCR was applied to amplify mFasL cDNA from the total RNA of activated mouse spleen lymphocytes. The cDNA was inserted into a T cloning vector, then subcloned into pLNCX 2. After transfection of chondrocytes, expression of FasL cDNA was detected by FACS, and activity of expressed product was analyzed by single mixed lymphocyte reaction(SMLC). RESULTS: mFasL cDNA fragment of 0.855 kb was successfully cloned and verifiedby sequencing. The transfection efficiency of mFasL cDNA in chondrocytes determined by FACS was 60.64%. Expressed product could evidently inhibit SMLC of allogeneic lymphocytes. It’s stimulating index (SI) reduced to 11.71% as compare with the untransfected chondrocytes. CONCLUSION: Cloned recombinant pLNCX 2 FasL can effectively express mFasL in chondrocytes, and can evidently inhibit SMLC of allogeneic lymphocytes.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2003年第4期326-328,337,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家重点基础研究发展规划 (973)资助 (No.G1 9990 5430 4 )
关键词 逆转录病毒 FASL RT—PCR 软骨细胞 T—A克隆 retrovirus FasL RT PCR chondrocyte T A cloning
  • 相关文献

参考文献11

  • 1[1]Streilein JW. Unraveling immune privilige [J]. Science,1995, 270: 1158-1159.
  • 2[2]Suda T, Takahashi T, Goldtein P, et al. Molecular cloning and expression of Fas Ligand,the novel member of the tumor necrosis factor family [J]. Cell, 1993, 75: 1169-1178.
  • 3[3]Griffith TS, Rrunner T, Fletcher SM, et al. Fas Ligand induced apoptosis as a mechanism of immune privilege [J]. Science, 1995, 270: 1189-1192.
  • 4[4]Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection [J]. Nature, 1995, 377: 630-632.
  • 5[5]Lau HT, Yu M, Fontana A, et al. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice [J]. Science, 1996, 273: 109-112.
  • 6[6]Yagita H, Seino K, Kayagaki N, et al. CD95 ligand in graft rejection [J]. Nature, 1996, 379: 682.
  • 7[7]Al1ison J, Georgiou HM, Strasser A, et al. Transgeneic expression of CD95 ligand on islet cells induces a granulocytic infiltration but does not confer immune privilege upon lslet allografts[J]. Proc Natl Acad Sci USA, 1997, 94: 3943-3947.
  • 8[8]Kang SM, Daren B, Schneider F, et al. Fas ligand expression in islets of langerhans does not confer immune privilege and instead targets them for rapid destruction [J]. Nat Med, l997, 3: 738-743.
  • 9[9]Zhang H, Yang Y, Horton JL, et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer [J]. J Clin Invest, 1997, 100(8): 1951-1957.
  • 10[10]Batteux F, Lores P, Buccchini D, et al. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis[J]. J Immunol, 2000, 164: 1681-1688.

同被引文献7

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部